Centre for Nano-Vaccine
Statens Serum Institut has established Centre for Nano-Vaccine in cooperation with the University of Copenhagen, Forschungs-Zentrum Borstel, Germany and Lund University in Sweden. The Centre has received 36 mill DKK from the Danish Research Council
The aim is to establish a Centre in the Oresund region, which effectively can design and develop new vaccines against some the of world’s most outspread infectious diseases such as influenza, tuberculosis and Type A Streptococci. The existing vaccines are either not effective enough (TB and influenza) or there is no vaccine at all (streptococci).
Infectious diseases are controlled in the body of various immune mechanisms and common to many infectious diseases is that infection occurs through mucous membranes in the airways. The centre will use a range of new knowledge in nano- and biotechnology, which makes it possible to optimize the design of vaccines aimed at strengthening immune responses in the airways.
Development of preventive vaccines against existing and emerging infectious diseases is of major importance for society. The unique collaboration of the centre will create an efficient and accelerated development of vaccines against the diseases that affect many people and may have a fatal off-time, and knowledge could also be used in the development of vaccines against future illnesses. For more information, please visit our web-site: www.nano-vaccine.org
Last revised 21 December 2011